Biomedical Value Fund, L.P.
Biomedical Value Fund, L.P. is a hedge fund based in Greenwich, Connecticut. According to its most recent Form D, filed Dec 17, 2025, the fund has sold $623,468,953 of interests to 93 investors since its first sale in Sep 2011. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Great Point GP, LLC; Jeffrey Jay; Great Point Partners, LLC.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
The firm that manages it, Great Point Partners, LLC, files Form 13F. Its page shows the firm's disclosed stock holdings and an estimate derived from them. Those figures describe the firm as a whole, not this fund.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $623,468,953Cumulative sales reported on Form D
- Investors
- 93
- First sale
- Sep 30, 2011
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Great Point GP, LLC; Jeffrey Jay; Great Point Partners, LLC
- Latest Form D
- Dec 17, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 17, 2025 | Form D/A (amendment) | $623,468,953 | 93 | SEC.gov ↗ |
| Dec 18, 2024 | Form D/A (amendment) | $605,993,169 | 114 | SEC.gov ↗ |
| Dec 19, 2023 | Form D/A (amendment) | $597,314,602 | 116 | SEC.gov ↗ |
| Dec 23, 2022 | Form D/A (amendment) | $568,384,754 | 103 | SEC.gov ↗ |
| Dec 20, 2021 | Form D | $549,293,586 | 98 | SEC.gov ↗ |
| Dec 20, 2021 | Form D/A (amendment) | $50,667,808 | 98 | SEC.gov ↗ |
| Dec 17, 2020 | Form D/A (amendment) | $498,625,778 | 118 | SEC.gov ↗ |
| Feb 27, 2019 | Form D | $1,422,799 | 4 | SEC.gov ↗ |
8 Form D filings in the SEC's electronic records (2008 onward), the earliest on Feb 27, 2019. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (2)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| Biomedical Offshore Value Fund, Ltd. | $772,302,554 | 73 | Dec 17, 2025 |
| BIOMEDICAL VALUE FUND, L.P. (this page) | $623,468,953 | 93 | Dec 17, 2025 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about Biomedical Value Fund, L.P.
What is the minimum investment for Biomedical Value Fund, L.P.?
Biomedical Value Fund, L.P.'s latest Form D, filed Dec 17, 2025, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Biomedical Value Fund, L.P.?
Biomedical Value Fund, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has Biomedical Value Fund, L.P. raised?
Biomedical Value Fund, L.P. reports $623,468,953 sold from 93 investors on its Form D filed Dec 17, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Biomedical Value Fund, L.P. based?
Biomedical Value Fund, L.P. is based in Greenwich, Connecticut and is managed by Great Point Partners, LLC.
When did Biomedical Value Fund, L.P. launch?
Biomedical Value Fund, L.P. reports its first sale in Sep 2011.
Size compared with every hedge fund
Raised more than 90% of the 881 hedge funds based in Connecticut, and more than 84% of all 10,161 that report sales.